Fig. 4From: Diabetes treatment intensification and associated changes in HbA1c and body mass index: a cohort studyMedian HbA1c and BMI and confidence intervals by intensification group over time: metformin+ insulin (Panel a); switch to insulin monotherapy (Panel b). Patients are allocated into these drug treatment exposures at treatment intensification persistence on medication is not required. Confidence intervals were calculated using the maximum Harrell-Davis standard errorBack to article page